Back to results
CompletedPhase 3

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

NCT01167881

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

1245.28.10005 Boehringer Ingelheim Investigational Site

Phoenix, Arizona, United States

+181 additional locations

View on ClinicalTrials.gov
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes — TrialFind